文献速递流行病学与生物统计

基于剂量-反应模型的网状Meta分析中证据一致性评估方法

Methods to assess evidence consistency in dose-response model based network meta-analysis.
PubMed 文献 · Stat Med · 2021-12-05

网状Meta分析(NMA)同时估计多种相对治疗效果,但剂量等治疗定义异质性可违背一致性假设。基于模型的NMA(MBNMA)方法可估计功能性剂量-反应关系,避免合并不同剂量。本文描述剂量-反应MBNMA模型中检查不一致性的方法,包括全局和局部(节点分割)检验,并考虑剂量探索试验中常见的≥3臂研究。采用比较中重度银屑病生物制剂的网络进行说明,显示未能正确刻画剂量-反应可引入明显不一致。

要点

  • 剂量-反应MBNMA中一致性评估需考虑剂量-反应函数的选择。
  • 全局和局部(节点分割)检验可处理剂量探索试验中常见的≥3臂研究。
  • 比较Emax与指数剂量-反应函数显示,错误刻画剂量-反应可引入明显不一致。

核心结论

  • 剂量-反应MBNMA中一致性评估需结合剂量-反应函数选择,正确刻画剂量-反应对获得稳健相对效应至关重要。

研究设计与样本

  • 方法学文章,描述剂量-反应MBNMA模型中检查不一致性的全局和局部(节点分割)检验方法,并用比较中重度银屑病生物制剂的网络进行说明。

主要发现

  • 比较Emax与指数剂量-反应函数的结果显示,未能正确刻画剂量-反应可引入明显不一致。
  • 节点分割可进行的比较数量取决于所选剂量-反应函数的复杂性。
  • 剂量探索试验通常比较同一药物的多个剂量,评估不一致性的范围有限,但这些设计有助于从一开始防止不一致。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 剂量探索试验通常比较同一药物的多个剂量,提供评估不一致性的范围有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Network meta-analysis (NMA) simultaneously estimates multiple relative treatment effects based on evidence that forms a network of treatment comparisons. Heterogeneity in treatment definitions, such as dose, can lead to a violation of the consistency assumption that underpins NMA. Model-based NMA (MBNMA) methods have been proposed that allow functional dose-response relationships to be estimated within an NMA, which avoids lumping different doses together and thereby reduces the likelihood of inconsistency. Dose-response MBNMA relies on appropriate specification of the dose-response relationship as well as consistency of relative effects. In this article we describe methods to check for inconsistency in dose-response MBNMA models. Global and local (node-splitting) tests for inconsistency are described that account for studies with ≥3 arms that are typical in dose-finding trials. We show that consistency needs to be assessed with respect to the choice of dose-response function. We illustrate the methods using a network comparing biologics for moderate-to-severe psoriasis. By comparing results from an Emax and an exponential dose-response function we show that failure to correctly characterise the dose-response can introduce apparent inconsistency. The number of comparisons for which node-splitting is possible is also shown to be dependent on the complexity of the selected dose-response function. We highlight that the nature of dose-finding studies, which typically compare multiple doses of the same agent, provide limited scope to assess inconsistency, but these study designs help guard against inconsistency in the first place. We demonstrate the importance of assessing consistency to obtain robust relative effects to inform drug-development and policy decisions.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Pedder H, Dias S, Boucher M, et al. Methods to assess evidence consistency in dose-response model based network meta-analysis. Stat Med. 2021. PMID: 34866221. doi:10.1002/sim.9270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。